Chinese herbal medicine as adjunctive therapy to chemotherapy for breast Cancer: A systematic review and meta-analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Sun, Xu ^a   Zhang, Xing ^a,b   Nian, Jia Yun ^a,b   Guo, Jiao ^a,b   Yin, Yi ^c   Zhang, Gan Lin ^a   Yu, Ming Wei ^a   Zhang, Yi ^a   Wang, Xiao Min ^a   Yang, Guo Wang ^a   Yang, Lin ^a   Cheng, Pei Yu ^a   Li, Jin Ping ^a,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; BREAST CANCER; CANCER CHEMOTHERAPY; CHINESE MEDICINE; HERBAL MEDICINE; HUMAN; LEUKOCYTE COUNT; MEDIAN SURVIVAL TIME; META ANALYSIS; PERSONAL EXPERIENCE; PHYSICIAN; POST TREATMENT SURVIVAL; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

EID: 84966350721     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/3281968     Document Type: Review

References (69)

1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, "Global cancer statistics, 2012, " CA Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87-108, 2015.
2. L. You, R. An, K. Liang, and X. Wang, "Anti-breast cancer agents from Chinese herbal medicines, " Mini-Reviews in Medicinal Chemistry, vol. 13, no. 1, pp. 101-105, 2013.
3. L. Del Mastro, A. Fabi, M. Mansutti et al., "Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments, " BMC Cancer, vol. 13, article 164, 2013.
4. D. Amadori, O. Nanni, M. Marangolo et al., "Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study, " Journal of Clinical Oncology, vol. 18, no. 17, pp. 3125-3134, 2000.
5. P. Rastogi, S. J. Anderson, H. D. Bear et al., "Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27, " Journal of Clinical Oncology, vol. 26, no. 5, pp. 778-785, 2008.
6. K. Bóer, I. Ĺang, E. Juhos, T. Pintér, and J. Sźantó, "Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC), " Pathology & Oncology Research, vol. 9, no. 3, pp. 166-169, 2003.
7. P. Harris and R. Rees, "The prevalence of complementary and alternative medicine use among the general population: a systematic review of the literature, " Complementary Therapies in Medicine, vol. 8, no. 2, pp. 88-96, 2000.
8. E. Ernst, "Prevalence of use of complementary/alternative medicine: a systematic review, " Bulletin of the World Health Organization, vol. 78, no. 2, pp. 252-257, 2000.
9. H. A. Tindle, R. B. Davis, R. S. Phillips, and D. M. Eisenberg, "Trends in use of complementary and alternative medicine by us adults: 1997-2002, " Alternative Therapies in Health and Medicine, vol. 11, no. 1, pp. 42-49, 2005.
10. C. C. L. Xue, A. L. Zhang, V. Lin, C. Da Costa, and D. F. Story, "Complementary and alternative medicine use in Australia: a national population-based survey, " Journal of Alternative and Complementary Medicine, vol. 13, no. 6, pp. 643-650, 2007.
11. E. Ernst and A. White, "The BBC survey of complementary medicine use in theUK, " ComplementaryTherapies inMedicine, vol. 8, no. 1, pp. 32-36, 2000.
12. W. J. Millar, "Use of alternative health care practitioners by Canadians, " Canadian Journal of Public Health, vol. 88, no. 3, pp. 154-158, 1997.
13. U. Wolf, S. Maxion-Bergemann, G. Bornhöft, P. F. Matthiessen, and M. Wolf, "Use of complementarymedicine in Switzerland, " Forschende Komplementarmedizin, vol. 13, no. 2, pp. 4-6, 2006.
14. B. Hanssen, S. Grimsgaard, L. LaunsØ, V. FØnnebØ, T. Falkenberg, and N. K. Rasmussen, "Use of complementary and alternative medicine in the Scandinavian countries, " Scandinavian Journal of Primary Health Care, vol. 23, no. 1, pp. 57-62, 2005.
15. K. Thomas and P. Coleman, "Use of complementary or alternative medicine in a general population in Great Britain. Results from the National Omnibus survey, " Journal of Public Health, vol. 26, no. 2, pp. 152-157, 2004.
16. B. Wang, The Yellow Emperors Classic of Internal Medicine-Simple Questions, Peoples Health Publishing House, Beijing, China, 1979.
17. D. Tian, Spiritual Axis, Peoples Health Publishing House, Beijing, China, 2005.
18. I. Cohen, M. Tagliaferri, and D. Tripathy, "Traditional Chinese medicine in the treatment of breast cancer, " Seminars in Oncology, vol. 29, no. 6, pp. 563-574, 2002.
19. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, "Preferred reporting items for systematic reviews and meta-analyses: the PRISMAstatement, " OpenMedicine, vol. 3, no. 3, pp. e123-e130, 2009.
20. A. R. Jadad, R. A. Moore, D. Carroll et al., "Assessing the quality of reports of randomized clinical trials: is blinding necessary?" Controlled Clinical Trials, vol. 17, no. 1, pp. 1-12, 1996.
21. J. P. T. Higgins, D. G. Altman, P. C. GØtzsche et al., "The Cochrane Collaborations tool for assessing risk of bias in randomised trials, " The British Medical Journal, vol. 343, no. 7829, Article ID d5928, 2011.
22. X. G. Dang and L. Wang, "Evaluation of efficacy on breast cancer treated by Aidi injection plus CTF program of neoadjuvant chemotherapy and the impacts on serum sFas, " World Journal of Integrated Traditional andWestern Medicine, vol. 5, no. 1, pp. 54-56, 2010.
23. D. L. Barton, K. Burger, P. J. Novotny et al., "The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9, " Supportive Care in Cancer, vol. 21, no. 4, pp. 1185-1192, 2013.
24. X. D. Fang, "Clinical observation on Jianpi Yiqi formula combined with chemotherapy in the treatment of 30 cases with advanced breast cancer, " Journal of Traditional Chinese Medicine, vol. 50, supplement 1, pp. 174-176.
25. L. Fu and X. G. Kou, "Clinical observation on Aidi injection combined with chemotherapy in the treatment of 44 cases with breast cancer, " Journal of Practical Traditional ChineseMedicine, vol. 23, no. 8, p. 517.
26. R. Hong, Y. Q. Wu, and Y. Wu, "Effects of Xihuangwan in assistanr treatment of patients with advanced breast cancer, " Zhong Guo Zhong Yao Za Zhi, vol. 39, no. 6, pp. 1120-1123, 2014.
27. Z. F. Huang, J. S. Wei, Z. Y. Shi, and K. Zhong, "Study of Bazhen decoction and chemotherapy on mammary cancer in metaphase or later period, " Xian Dai Zhong Xi Yi Jie He Za Zhi, vol. 12, no. 11, pp. 1123-1126, 2003.
28. Z. F. Huang, J. B. Liu, Q. S. Chen, H. Z. Li, Z. J. Zhang, and C. J. Huang, "The influence of Jianpi Xiaoji Tang combined with chemotherapy on life quality and immunologic function in late stage of mammary cancer, " Journal of New Chinese Medicine, vol. 39, no. 5, pp. 88-89.
29. Z. F. Huang, J. S. Wei, H. Z. Li, Z. Q. Tan, Z. J. Zhang, and C. Chen, "Effect of Shenqi Fuzheng injection combined with chemotherapy on thirty patients with advanced breast cancer, " Chinese Journal of Integrated Traditional andWesternMedicine, vol. 28, no. 2, pp. 152-154, 2008.
30. C. J. Huang, J. B. Liu, and T. H. Liao, "Effect of Astragalus injection combined chemotherapy on life quality and immune function in advanced breast cancer, " Nei Mongol Journal of Traditional Chinese Medicine, vol. 32, no. 32, pp. 66-67.
31. X. Q. Li, Y. Wang, S. T. Zhao, X. H. Ni, and S. Q. Ma, "Clinical observationonno. 1 decoctionofRukangaffectingbreast cancer matastasis of 61 cases, " Chinese Journal of Traditional Medical Science and Technology, vol. 10, no. 5, pp. 305-306.
32. X. Q. Li and S. B. Gong, "Effect of Aidi injection combined with CEF regimn chemotherapy in the treatment of breast cancer, " Pharmacology and Clinics of ChineseMateriaMedica, vol. 3, no. 22, pp. 176-177.
33. X. A. Lu, "Effect of Astragalus Injection on the Quality of breast cancer patients, " Zhong Guo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu, vol. 8, no. 11, pp. 36-37.
34. Y. Lv, L. Z. Huang, D. Mao, X. J. Dai, J. Yang, and S. Q. Zhang, "Clinical research on treatment of advanced breast cancer based on Yiqi Huoxue method combined with chemotherapy, " Acta Chinese Medicine and Pharmacology, vol. 42, no. 3, pp. 93-96.
35. X. L. Ni, "Clinical study of gaolishen injection combined with chemotherapy for the advanced breast cancer, " China Practical Medical, vol. 1, no. 4, pp. 64-65.
36. D. Ṕerol, J. Provencal, A.-C. Hardy-Bessard et al., "Can treatment with Cocculine improve the control of chemotherapyinduced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial, " BMC Cancer, vol. 12, article 603, 2012.
37. M. H. Qi, Clinical Research of Breast Cancer Treatments by Yiqi Yangxue Shugan Decotion Assisting TE Chemotherapy, The First Clinical Medical College, Nanjing University of Chinese Medicine, 2010.
38. L. Qin, "Effect of Fuzheng Yiqi Jiedu decoction in the treatment of 39 breast cancer cases after surgery, " Traditional Chinese Medicine Rearch, vol. 26, no. 7, pp. 19-21.
39. V. F. Semiglazov, V. V. Stepula, A. Dudov, J. Schnitker, and U. Mengs, "Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial, " Anticancer Research, vol. 26, no. 2, pp. 1519-1529, 2006.
40. T. Shen, "Clinical observation of Aiyishu injection combined with chemotherapy in advanced stage breast cancer, " China Medicine Guides, vol. 4, no. 26, pp. 44-45.
41. W. H. Sun, M. Y. Luo, and J. Yu, "Preventive effect of Zanfan pill on the myelosupression of breast cancer patients receiving chemotherapy, " Strait Pharmaceutical Journal, vol. 22, no. 5, pp. 100-102.
42. Y. H. Wang, Effect on Quality of Life about Paients with Breast Cancer Received Neoadjuvant Chemotherapy and Taohong Siwu Tang, Guangzhou University of Chinese Medicine, 2007.
43. L. F. Wang, Impact on QOL of Patients with Advanced Breast Cancer Treated by YiQiJianPi and HuaYuJieDu Method Combined with TE Regiment Chemotherapy, The First Clinical Medical College, NanjingUniversity of ChineseMedicine, 2010.
44. H. Y. Wen, Y. L. Ma, and C. X. Wang, "Effect on QOL and immunity of patients with advanced breast cancer treated by fuzheng xiaoyan decoction combined with chemotherapy, " Jiang Su Zhong Yi Yao, vol. 42, no. 8, pp. 23-24.
45. L. G. Xiong, "Study on the effect of Fuzheng Xiaoji recipe combined with chemotherapy on the life quality and serum tumormarkers of late breast cancer patients, " Yunnan Journal of Traditional ChineseMedicine andMateriaMedica, vol. 33, no. 4, pp. 14-15, 2012.
46. L. Yang, "Clinical study of Aidi injection combined with chemotherapy on advanced breast cancer, " Chinese Journal of Integrated Traditional and Western Medicine, vol. 24, no. 8, pp. 755-756, 2004.
47. G. W. Yang, Y. M. Xu, Q. Fu et al., "Clinical observation on Gubne Yiliu II combined with chemotherapy in the treatment of 28 cases of advanced breast cancer, " Journal of Traditional Chinese Medicine, vol. 49, no. 12, pp. 1081-1083.
48. S.-Y. Yi, K.-J. Nan, S.-J. Chen et al., "Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer, " Chinese Journal of Integrated Traditional and Western Medicine, vol. 28, no. 1, pp. 68-70, 2008.
49. W. H. Zhang, C. Y. Zhao, X. F. Zhang et al., "Effect of radix astragali taohong decoction on dellular immune function in breast cancer patients with postoperative chemotherapy, " Chinese Journal of Breast Disease, vol. 2, no. 4, pp. 137-143.
50. Y. C. Zhang, X. J. Li, Y. J. Jia, J. Chen, and Y. Y. Sun, "Clinical observation of "Fuzheng Quyu Jiedu Prescription" combining with chemotherapy in treating postoperative breast cancer, " Shanghai Journal of Traditional Chinese Medicine, vol. 45, no. 11, pp. 64-66, 2011.
51. X. Y. Zhang and G. C. Li, "Clinical study of Tiaogan Lipi method combined with Neoadjuvan chemotherapy for the treatment of breast cancer, " Modern Practical Medicine, vol. 25, no. 10, pp. 1145-1146.
52. R. Zhong, Clinical Rearch of Shu Gan Tiao Li Chong Ren Decoction with the Chemotherapy in the Treatment of Breast Cancers QOL, The First Clinical Medical College, Nanjing University of Chinese Medicine, 2009.
53. M. P. Coleman, "Trends in breast cancer incidence, survival, and mortality, " The Lancet, vol. 356, no. 9229, pp. 590-593, 2000.
54. A. Glaus, B. Fäh, R. Hornung, H. Senn, and F. Stiefel, "Breast cancer prevention behaviour: a perspective of women from three language regions of Switzerland, " Pflege, vol. 17, no. 6, pp. 385-394, 2004.
55. L. Lohr, "Chemotherapy-induced nausea and vomiting, " Cancer Journal, vol. 14, no. 2, pp. 85-93, 2008.
56. S. Hori, I. Mihaylov, J. C. Vasconcelos, and M. McCoubrie, "Patterns of complementary and alternative medicine use amongst outpatients in Tokyo, Japan, " BMC Complementary and Alternative Medicine, vol. 8, article 14, 2008.
57. H.-J. Seo, S.-M. Baek, S. G. Kim, T.-H. Kim, and S. M. Choi, "Prevalence of complementary and alternative medicine use in a community-based population in South Korea: a systematic review, " ComplementaryTherapies inMedicine, vol. 21, no. 3, pp. 260-271, 2013.
58. L. L. D. Zhong, H.-Y. Chen, W. C. S. Cho, X.-M. Meng, and Y. Tong, "Theefficacy of Chinese herbalmedicine as an adjunctive therapy for colorectal cancer: a systematic review and metaanalysis, " Complementary Therapies in Medicine, vol. 20, no. 4, pp. 240-252, 2012.
59. F. Cheung, "TCM: made in China, " Nature, vol. 480, no. 7378, pp. S82-S83, 2011.
60. A. Bensoussan, N. J. Talley, M. Hing, R. Menzies, A. Guo, and M. Ngu, "Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial, " The Journal of the American Medical Association, vol. 280, no. 18, pp. 1585-1589, 1998.
61. D. C. Cherkin, K. J. Sherman, A. L. Avins et al., "A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain, " Archives of Internal Medicine, vol. 169, no. 9, pp. 858-866, 2009.
62. A. T. Lathia, S. M. Jung, and L. X. Chen, "Efficacy of acupuncture as a treatment for chronic shoulder pain, " Journal of Alternative and ComplementaryMedicine, vol. 15, no. 6, pp. 613-618, 2009.
63. E. A. Macklin, P. M. Wayne, L. A. Kalish et al., "Stop Hypertension with the Acupuncture Research Program(SHARP): results of a randomized, controlled clinical trial, " Hypertension, vol. 48, no. 5, pp. 838-845, 2006.
64. W. C. S. Cho and H.-Y. Chen, "Clinical efficacy of traditional chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis, " Cancer Investigation, vol. 27, no. 3, pp. 334-344, 2009.
65. S. G. Li, H. Y. Chen, C. S. Ou-Yang et al., "Theefficacy of chinese herbal medicine as an adjunctive therapy for advanced nonsmall cell lung cancer: a systematic review and meta-analysis, " PLoS ONE, vol. 8, no. 2, Article ID e57604, 2013.
66. P. Wu, J. J. Dugoua, O. Eyawo, and E. J. Mills, "Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis, " Journal of Experimental and Clinical Cancer Research, vol. 28, article 112, 2009.
67. W. Kim, W.-B. Lee, J.-W. Lee et al., "Traditional herbalmedicine as adjunctive therapy for breast cancer: a systematic review, " Complementary Therapies in Medicine, vol. 23, no. 4, pp. 626-6232, 2015.
68. N. E. Haddad and O. Palesh, "Acupuncture in the treatment of cancer-related psychological symptoms, " Integrative Cancer Therapies, vol. 13, no. 5, pp. 371-385, 2014.
69. E. Ernst, K. Schmidt, and M. Baum, "Complementary/alternative therapies for the treatment of breast cancer. A systematic review of randomized clinical trials and a critique of current terminology, " Breast Journal, vol. 12, no. 6, pp. 526-530, 2006.